FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileSiegfried Holding AG
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Discussion
SGFEF
Siegfried Holding AG Stock AnalysisComprehensive stock analysis for Siegfried Holding AG (SGFEF) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisSGFEF
SGFEF
Siegfried Holding AG
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Discussion
SGFEF
  1. Home
  2. Stocks
  3. Siegfried Holding AG

Siegfried Holding AG

🇺🇸SGFEF•OTC

Siegfried Holding AG

🇺🇸SGFEF•OTC
Market cap
$4.58B
P/E ratio
16.68

Your view on SGFEF

Mkt Cap
$4.58B
P/E
16.68
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Siegfried Holding AG

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Marcel Imwinkelried
Headquarters
Untere Bruehlstrasse 4, Zofingen, CH
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Marcel Imwinkelried
Headquarters
Untere Bruehlstrasse 4, Zofingen, CH
Description

Siegfried Holding AG engages in the life sciences business worldwide. The company develops and produces active pharmaceutical ingredients (APIs) and intermediates, as well as finished dosage forms, including solid oral dosage forms, and sterile and aseptic filling injectables, ophthalmics, and inhalative products.

It offers contract development and manufacturing services, including pharmaceutical and analytical development, process and analytical transfer, commercial manufacturing and packaging, and scale up and clinical trial material production.

In addition, the company provides APIs and controlled substances focusing on anesthetics, pain treatment applications, and central nervous and respiratory diseases. Further, it licenses oral solid and sterile products; assembles registration dossiers; and offers a common technical document for various products.

The company was founded in 1873 and is headquartered in Zofingen, Switzerland.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Siegfried Holding AG. Starting points for Siegfried Holding AG: P/E 16.7, EPS $3.90, beta 0.80 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Siegfried Holding AG. Siegfried Holding AG does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Siegfried Holding AG. Trailing twelve-month EPS for Siegfried Holding AG stands at $3.90. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Wall Street analysts· not FRC research
Nov 22, 2026

Buy

Analyst ratings

4 ratings
  • Strong Buy0
  • Buy2
  • Hold2
  • Sell0
  • Strong Sell0
More →

Earnings per share estimates

Per shareThis quarterDec 2026Next quarterJun 2027This yearYear to Dec 2026Next yearYear to Dec 2027
Average estimateCHF 2.39CHF 1.61CHF 3.84CHF 4.36
Lowest estimateCHF 2.38CHF 1.61CHF 3.74CHF 4.25
Highest estimateCHF 2.40CHF 1.61CHF 4.01CHF 4.56
Number of analysts1111
A year agoCHF 2.21CHF 1.89CHF 3.85—
Growth vs a year ago+8.1%−14.9%−0.4%—

Revenue estimates

TotalThis quarterDec 2026Next quarterJun 2027This yearYear to Dec 2026Next yearYear to Dec 2027
Average estimateCHF 752.38MCHF 635.95MCHF 1.35BCHF 1.47B
Lowest estimateCHF 752.38MCHF 635.95MCHF 1.34BCHF 1.43B
Highest estimateCHF 752.38MCHF 635.95MCHF 1.37BCHF 1.56B
Number of analysts111112
A year agoCHF 674.67MCHF 619.52MCHF 1.33B—
Growth vs a year ago+11.5%+2.7%+1.8%—

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Siegfried Holding AG. Siegfried Holding AG has reported as a listed company since 2014. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold SGFEF12 companies
More Drug Manufacturers - Specialty & Generic companies
TickerTypeCompanySectorExchangeMkt cap
ESAIYEisai Co., Ltd.HealthcareOTC$9.4B
ESALFEisai Co., Ltd.HealthcareOTC$9.3B
ETONEton Pharmaceuticals, Inc.HealthcareNASDAQ$1.8B
ETSTEarth Science Tech, Inc.HealthcareOTC$32.3M
EVIOEVIO, Inc.HealthcareOTC$1.9M
EVOEvotec SEHealthcareNASDAQ$468.8M
EVOTFEvotec SEHealthcareOTC$1.4B
EVRRFMolecule Holdings Inc.HealthcareOTC$626,130
EWPIEmerging World Pharma, Inc.HealthcareOTC$11,930
EXL.AXElixinol Wellness LimitedHealthcareASX—
EXMTAnything Technologies Media, Inc.HealthcareOTC$2.4M
FFNTF4Front Ventures Corp.HealthcareOTC$62,300
Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Siegfried Holding AG.

SGFEF AnalysisFair
Past
1
Growth
1
Health
3
Profit
3
Value
2